HK6190A - Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives - Google Patents
Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives Download PDFInfo
- Publication number
- HK6190A HK6190A HK61/90A HK6190A HK6190A HK 6190 A HK6190 A HK 6190A HK 61/90 A HK61/90 A HK 61/90A HK 6190 A HK6190 A HK 6190A HK 6190 A HK6190 A HK 6190A
- Authority
- HK
- Hong Kong
- Prior art keywords
- hydroxypyrid
- carbon atoms
- hydroxy
- aliphatic hydrocarbon
- hydrocarbon group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8208608 | 1982-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK6190A true HK6190A (en) | 1990-02-02 |
Family
ID=10529232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK61/90A HK6190A (en) | 1982-03-24 | 1990-01-25 | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4840958A (instruction) |
| EP (1) | EP0093498B1 (instruction) |
| JP (3) | JPS58174319A (instruction) |
| CY (1) | CY1502A (instruction) |
| DE (2) | DE3367849D1 (instruction) |
| GR (1) | GR78491B (instruction) |
| HK (1) | HK6190A (instruction) |
| NL (1) | NL990031I2 (instruction) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| EP0305646B1 (en) * | 1983-03-24 | 1996-11-13 | Btg International Limited | 3-Hydroxypyrid-4-ones and pharmaceutical compositions |
| GB8325494D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| US4912118A (en) * | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
| USRE34313E (en) * | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
| WO1989009211A1 (en) * | 1988-03-31 | 1989-10-05 | The Royal Free Hospital School Of Medicine | Process for producing pyrid-4-ones |
| GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
| US5298525A (en) * | 1992-11-23 | 1994-03-29 | University Technologies International, Inc. | Diabetes prevention and treatment |
| US6046219A (en) * | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
| US5849587A (en) * | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| EP0833627B1 (en) | 1995-06-10 | 2004-08-18 | Vitra Pharmaceuticals Ltd. | Iron compounds, compositions, methods of making the same and uses thereof |
| US6004986A (en) * | 1997-05-08 | 1999-12-21 | The University Of Virginia Patent Foundation | Method for treating cerebral vasospasm and cerebral ischemia using iron chelators and pharmaceutical compositions therefor |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| IL135884A (en) * | 2000-04-30 | 2005-08-31 | Yissum Res Dev Co | Method for measuring non-transferrin bound iron |
| CA2421410C (en) * | 2000-09-19 | 2009-11-10 | Vitra Pharmaceuticals Limited | Iron compositions |
| US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| GB0211500D0 (en) | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| CA2504512A1 (en) | 2002-10-30 | 2004-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Molecules and methods using same for measuring non-transferrin bound iron |
| WO2004041151A2 (en) | 2002-11-07 | 2004-05-21 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| KR20130044381A (ko) * | 2010-03-04 | 2013-05-02 | 머크 샤프 앤드 돔 코포레이션 | 카테콜 ｏ－메틸 트랜스퍼라제의 억제제 및 정신병적 장애의 치료에서의 그의 용도 |
| GB201007209D0 (en) | 2010-04-29 | 2010-06-16 | King S College London | Compound |
| WO2012137202A1 (en) | 2011-04-05 | 2012-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci) |
| WO2018085619A1 (en) * | 2016-11-07 | 2018-05-11 | Arbutus Biopharma, Inc. | Substituted pyridinone-containing tricyclic compounds, and methods using same |
| TWI801517B (zh) | 2018-03-12 | 2023-05-11 | 加拿大商愛彼特生物製藥公司 | 經取代的2-吡啶酮三環化合物、其類似物及其使用方法 |
| CN112839654A (zh) | 2018-04-12 | 2021-05-25 | 爱彼特生物制药公司 | 制备取代的含吡啶酮的三环化合物的方法 |
-
1983
- 1983-03-23 GR GR70868A patent/GR78491B/el unknown
- 1983-03-24 CY CY1502A patent/CY1502A/xx unknown
- 1983-03-24 EP EP83301659A patent/EP0093498B1/en not_active Expired
- 1983-03-24 DE DE8383301659T patent/DE3367849D1/de not_active Expired
- 1983-03-24 DE DE1999175062 patent/DE19975062I1/de active Pending
- 1983-03-24 JP JP58049677A patent/JPS58174319A/ja active Granted
- 1983-03-24 JP JP58049676A patent/JPS58174318A/ja active Granted
-
1986
- 1986-11-20 US US06/933,338 patent/US4840958A/en not_active Expired - Lifetime
-
1990
- 1990-01-25 HK HK61/90A patent/HK6190A/en not_active IP Right Cessation
-
1992
- 1992-02-18 JP JP4030887A patent/JPH0757749B2/ja not_active Expired - Lifetime
-
1999
- 1999-10-06 NL NL990031C patent/NL990031I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3367849D1 (en) | 1987-01-15 |
| NL990031I1 (nl) | 1999-12-01 |
| JPH0680636A (ja) | 1994-03-22 |
| NL990031I2 (nl) | 2000-04-03 |
| US4840958A (en) | 1989-06-20 |
| EP0093498A3 (en) | 1984-07-11 |
| JPH0460987B2 (instruction) | 1992-09-29 |
| JPS58174318A (ja) | 1983-10-13 |
| DE19975062I1 (de) | 2003-09-04 |
| JPS58174319A (ja) | 1983-10-13 |
| CY1502A (en) | 1990-08-03 |
| JPH0515693B2 (instruction) | 1993-03-02 |
| EP0093498A2 (en) | 1983-11-09 |
| EP0093498B1 (en) | 1986-11-26 |
| JPH0757749B2 (ja) | 1995-06-21 |
| GR78491B (instruction) | 1984-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0093498B1 (en) | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives | |
| EP0120669B1 (en) | Hydroxypyridones, and their pharmaceutical compositions | |
| EP0138421B1 (en) | Hydroxypyridone derivatives and pharmaceutical compositions containing them | |
| EP0138420B1 (en) | Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives | |
| US5104865A (en) | Iron complexes of hydroxypyridones useful for treating iron overload | |
| US5624901A (en) | 3-hydroxy-2(1H)-pyridinone chelating agents | |
| GB2118176A (en) | Pharmaceutical compositions | |
| USRE36831E (en) | Iron-pyridone complexes for anemia | |
| US4550101A (en) | Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia | |
| JPH04230264A (ja) | ２，４−および２，５−置換ピリジン−ｎ−オキシド | |
| USRE34313E (en) | Pharmaceutical compositions | |
| GB2117766A (en) | Pharmaceutical compositions | |
| Kreppel et al. | Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice | |
| EP0305646B1 (en) | 3-Hydroxypyrid-4-ones and pharmaceutical compositions | |
| Molenda et al. | Enhancement of iron excretion via monoanionic 3-hydroxypyrid-4-ones | |
| KR970009042B1 (ko) | 1,4,10,13-테트라옥사-7,16-디아자씨클로옥타데칸 유도체와 상기 유도체를 함유한 약제학적 조성물 | |
| Mannani et al. | Synthesis of two novel thioacridinic derivatives and comparison of their in vitro biological activities |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |